News For VICL From The Last 14 Days Check below for free stories on VICL the last two weeks.
There are 3 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
January 28, 2010
|
| 10:54 EDT |  | VICL |
| | 06:33 EDT |  | VICL |
| theflyonthewall.com: | Vical completes enrollment in Allovectin-7 Phase lll Melanoma trial | | Vical Incorporated announced that the company has completed enrollment of the planned 375 subjects in its multinational Phase 3 trial of Allovectin-7(R) in patients with metastatic melanoma. Allovectin-7(R) is a novel gene-based immunotherapeutic with a unique mechanism of action that is fundamentally different from currently approved treatments, and has the potential to be the first new primary treatment approved for metastatic melanoma in nearly 20 years. :theflyonthewall.com |
|
|
January 26, 2010
|
| 06:36 EDT | | VICL |
| theflyonthewall.com: | Vical to present an overview of its DNA vaccine and adjuvant technologies | | Vical announced that the company will present an overview of its DNA vaccine and adjuvant technologies and an update on its clinical-stage vaccine development programs at the Phacilitate Vaccine Forum. :theflyonthewall.com |
|
|
|
Subscribe for More Information